CXCL9 and myocarditis: Interferon-responsive CXCL9+/CXCL10+ macrophages have emerged as a conserved pro-inflammatory myeloid subset in diverse cardiac injuries, including immune checkpoint inhibitor myocarditis and viral myocarditis [[32], [33], [34]].